EU Pharmacovigilence

Pharmacovigilance related activities of Member States and the European Medicines Agency concerning medicinal products for human use (2012 – 2014) – Update.

On 8 August 2016 the Commission adopted a report on the pharmacovigilance related activities of Member States and the European Medicines Agency (EMA). The report and the accompanying staff working document which describe the main activities of the collaborative EU system for monitoring and managing the safety of human medicines since the new legislation came into effect in 2012 until 2014 are available in publication format here: Report

The original version in all the EU official languages remains available here: Report

https://ec.europa.eu/health/human-use/pharmacovigilance/developments_en

 

Smarsh, Inc. assumes no liability for the accuracy or completeness of this information. Please consult with an attorney for specific information on specific rules and regulations and how they apply to your business.

  • Back to Regulations & Laws

Get a Quote

Tell us about yourself, and we’ll be in touch right away.

Smarsh handles information you submit to Smarsh in accordance with its Privacy Policy. By clicking "submit", you consent to Smarsh processing your information and storing it in accordance with the Privacy Policy and agree to receive communications from Smarsh and its third-party partners regarding products and services that may be of interest to you. You may withdraw your consent at any time by emailing privacy@smarsh.com.

Contact Us

Tell us about yourself, and we’ll be in touch right away.